Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: IB 367; IB 367-03; Iseganan hydrochloride; Iseganan oral rinse; Protegrin IB 367 Rinse

Latest Information Update: 25 Jul 2008

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ardea Biosciences
  • Class Antibacterials; Antifungals; Peptide antibiotics; Protegrins
  • Mechanism of Action Cell membrane modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cystic fibrosis-associated respiratory tract infections; Mycoses; Nosocomial pneumonia; Stomatitis

Most Recent Events

  • 23 Jun 2004 Discontinued - Phase-II/III for prevention of Nosocomial pneumonia in European Union (Buccal)
  • 23 Jun 2004 Discontinued - Phase-II/III for prevention of Nosocomial pneumonia in USA (Buccal)
  • 23 Jun 2004 Clinical data from a media release have been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top